Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These cases provide great insights into ALK translocation RCCs.
|
26848800 |
2016 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
There are only rare reports of RCC with an ALK-TMP3 fusion, and these tumours can express TFE3 on some unknown basis not related to a TFE3 translocation.
|
27450657 |
2016 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
There have been recent reports of a rare variant of renal cell carcinoma associated with upregulation of the anaplastic lymphoma kinase gene (ALK) arising as a consequence of chromosomal translocations.
|
24318419 |
2014 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These are likely to be incorporated into subsequent classifications and include thyroid-like follicular RCC, succinate dehydrogenase B mutation-associated RCC, ALK translocation RCC, tuberous sclerosis complex-associated RCC, and RCC with (angio) leiomyomatous stroma.
|
25753529 |
2015 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Regarding translocation renal cell carcinoma (RCC), TFE3, TFEB and ALK protein expression is crucial in establishing the diagnosis of Xp11.2 RCC, renal carcinoma with t(6;11)(p21;q12), and renal carcinoma with ALK rearrangement, respectively.
|
23957913 |
2013 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
|
29405994 |
2018 |
Renal Cell Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The currently recognized 2016 World Health Organization classification for RCC subtypes is briefly discussed, including new diagnostic entities (clear cell papillary RCC, hereditary leiomyomatosis and RCC-associated RCC, succinate dehydrogenase-deficient RCC, tubulocystic RCC, and acquired cystic disease-associated RCC) and areas of evolving RCC classification, such as transcription elongation factor B subunit 1 (TCEB1)-mutated RCC/RCC with angioleiomyoma-like stroma/RCC with leiomyomatous stroma, RCC associated with anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangement, thyroidlike follicular RCC, and RCC in neuroblastoma survivors.
|
27684973 |
2016 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Other subtypes included tuberous sclerosis-associated RCC (4.2%), anaplastic lymphoma kinase (ALK)-rearranged RCC (3.8%), thyroid-like RCC (1.4%), myoepithelial carcinoma (0.9%), and unclassified (7.5%).
|
29905933 |
2018 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.
|
29024210 |
2017 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Our report draws the attention to the possibility that VCL-ALK genotype can be involved in older patients unassociated with sickle cell trait, also expanding the spectrum to ALK-rearranged RCC.
|
31563285 |
2019 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
To date, less than 17 cases of RCCs with ALK rearrangements are reported in children and adults.
|
27554841 |
2016 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
ALK is a receptor tyrosine kinase, associated with many tumor types as diverse as anaplastic large cell lymphomas, inflammatory myofibroblastic tumors, breast and renal cell carcinomas, non-small cell lung cancer, neuroblastomas, and more.
|
30813562 |
2019 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
VCL-ALK renal cell carcinoma may represent the eighth sickle-cell nephropathy.
|
24698962 |
2014 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
None of the tested samples showed positive staining, which suggests that the incidence of ALK rearrangement-associated renal cell carcinomas is significantly lower in the Polish population, and indicates a potential association between ethnicity and occurrence of these rare neoplasms.
|
31677810 |
2019 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Finally, ALK-rearrangement RCC seems to have 2 different clinical settings, one with sickle cell trait (VCL-ALK fusion) and the other without (other fusions such as TPM3-ALK, EML4-ALK, and STRN-ALK fusions).
|
28181950 |
2017 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
ALK-tRCC is a rare subtype of adult RCC.
|
31627758 |
2019 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Based on the shared unique morphologic, immunophenotypic, and genetic features, it was proposed that these neoplasms belonged to a distinct subgroup of RCC frequently occurring in pediatric patients, which they have termed as ALK-rearranged RCC.
|
26773439 |
2016 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Follow-up data were analyzed for the two cases and eight other ALK-rearranged RCCs reported in the literature.
|
28199742 |
2017 |
Renal Cell Carcinoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
|
22743654 |
2012 |